you as you develop your own research programs and contribute to our growing bioeconomy. References 1. Shapiro B and Wilder C. Feb 2023. Bioproduction: Advancing the Bioeconomy. ATCC. https://www.atcc. org/blogs/2023/bioproduction 2. Guo M and Song W. The growing U.S. bioeconomy: Drivers, development and constraints. N Biotechnol 2019; 49:48-57. 3. Biden J. Sept 2022. Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy. The White House. https://www.whitehouse.gov/ briefing-room/presidential-actions/2022/09/12/ executive-order-on-advancing-biotechnology-andbiomanufacturing-innovation-for-a-sustainable-safeand-secure-american-bioeconomy/ 4. The Bioeconomy: A Primer. Sept 2022. Congressional Research Service. https://crsreports.congress.gov/ product/pdf/R/R46881 5. Bashor CJ et al. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov 2022; 21:655-675. 6. Weiskirchen S et al. A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless Problems. Cells 2023; 12(5): 682. 7. Shupe J et al. Gene therapy: challenges in cell culture scale-up. Curr Opin Biotechnol 2022; 75: 102721. 8. Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 2021; 11: 69. 9. Ma S et al. Current Progress in CAR-T Cell Therapy for Solid Tumors. Int J Biol Sci 2019; 15(12):2548-2560. 10. Foulke J et al. CAR-T Target Luciferase Reporter Cells can anable your breakthroughs in immuno-oncology. ATCC. https://www.atcc.org/resources/applicationnotes/luciferase-reporter-cancer-cell-lines-facilitatecar-t-development 11. CAR-T Target Luciferase Reporter Cells. ATCC. https:// www.atcc.org/cell-products/applications/immunooncology/car-t-target-luciferase-reporter-cells#t=pro ductTab&numberOfResults=24 12. Turner-Gillies E et al. ATCC Creates High-Titer Viral Production Cell Lines through CRISPR-Cas9 Gene Editing. ATCC. https://www.atcc.org/resources/ application-notes/generation-of-cell-lines-capable-ofproducing-high-titer-viral-stocks 13. Chang J. Adenovirus Vectors: Excellent Tools for Vaccine Development. Immune Netw 2021; 21(1): e6. 14. Kantardjieff A and Zhou W. Mammalian cell cultures for biologics manufacturing. Adv Biochem Eng Biotechnol 2014; 139:1-9. 15. Drexler HG and Uphoff CC. Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 2003; 39:75-90. 16. King S. Quantitative Controls Can Help Evaluate Sensitivity of Detection Systems. ATCC. https://www.atcc. org/resources/application-notes/use-of-quantitativemycoplasma-dna-controls-in-evaluating-sensitivity 17. Human Primary Immune Cells for Immunotherapy Research and More! ATCC. https://www.atcc.org/cellproducts/primary-cells/immune-cells#t=productTab& numberOfResults=24 18. Viral Reference Materials: Viral reference materials are crucial for standardization and reproducibility in gene therapy. ATCC. https://www.atcc.org/microbeproducts/virology/viral-reference-materials#t=produc tTab&numberOfResults=24 7https://www.atcc.org/resources/application-notes/luciferase-reporter-cancer-cell-lines-facilitate-car-t-development https://www.atcc.org/resources/application-notes/luciferase-reporter-cancer-cell-lines-facilitate-car-t-development https://www.atcc.org/resources/application-notes/luciferase-reporter-cancer-cell-lines-facilitate-car-t-development https://www.atcc.org/cell-products/applications/immuno-oncology/car-t-target-luciferase-reporter-cells#t=productTab&numberOfResults=24 https://www.atcc.org/blogs/2023/bioproduction https://www.atcc.org/cell-products/applications/immuno-oncology/car-t-target-luciferase-reporter-cells#t=productTab&numberOfResults=24 https://www.atcc.org/blogs/2023/bioproduction https://www.atcc.org/cell-products/applications/immuno-oncology/car-t-target-luciferase-reporter-cells#t=productTab&numberOfResults=24 https://www.atcc.org/cell-products/applications/immuno-oncology/car-t-target-luciferase-reporter-cells#t=productTab&numberOfResults=24 https://www.atcc.org/resources/application-notes/generation-of-cell-lines-capable-of-producing-high-titer-viral-stocks https://www.atcc.org/resources/application-notes/generation-of-cell-lines-capable-of-producing-high-titer-viral-stocks https://www.atcc.org/resources/application-notes/generation-of-cell-lines-capable-of-producing-high-titer-viral-stocks https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ https://crsreports.congress.gov/product/pdf/R/R46881 https://crsreports.congress.gov/product/pdf/R/R46881 https://www.atcc.org/resources/application-notes/use-of-quantitative-mycoplasma-dna-controls-in-evaluating-sensitivity https://www.atcc.org/resources/application-notes/use-of-quantitative-mycoplasma-dna-controls-in-evaluating-sensitivity https://www.atcc.org/resources/application-notes/use-of-quantitative-mycoplasma-dna-controls-in-evaluating-sensitivity https://www.atcc.org/cell-products/primary-cells/immune-cells#t=productTab&numberOfResults=24 https://www.atcc.org/cell-products/primary-cells/immune-cells#t=productTab&numberOfResults=24 https://www.atcc.org/cell-products/primary-cells/immune-cells#t=productTab&numberOfResults=24 https://www.atcc.org/microbe-products/virology/viral-reference-materials#t=productTab&numberOfResults=24 https://www.atcc.org/microbe-products/virology/viral-reference-materials#t=productTab&numberOfResults=24 https://www.atcc.org/microbe-products/virology/viral-reference-materials#t=productTab&numberOfResults=24